For example, whether the activated T lymphocytes that cause pathology in patients with CTLA‐4 deficiency are antigenic specific remains unclear,10 which requires further investigation and understanding of the molecular mechanisms underlying CTLA‐4 and immune disorders. This evidence concerns the gene CTLA4 and immune system disorder.